Cbd delivery methods
Pro Research Analysisby 
Searched over 200M research papers
Oral CBD Delivery Methods: Lipid-Based, Emulsions, and Nanoformulations
Oral delivery of cannabidiol (CBD) is challenging due to its poor water solubility and extensive first-pass metabolism, which limit its bioavailability. To address these issues, researchers have developed several advanced oral delivery systems. Lipid-based formulations, such as those using medium-chain triglycerides (MCT) or sesame oil, significantly improve CBD absorption compared to powder forms, but absorption can be variable among individuals 110. Self-emulsifying drug delivery systems (SEDDS) and self-nanoemulsifying drug delivery systems (SNEDDS) further enhance CBD’s solubility, provide more predictable and uniform absorption, and result in higher and faster peak plasma concentrations (Cmax) compared to traditional oil-based formulations 2910. Solid SNEDDS formulations also offer improved stability and flexibility for developing solid oral CBD products . Additionally, incorporating therapeutic deep eutectic solvents (THEDES) into SEDDS has shown promise for protecting CBD in the stomach and enhancing its oral delivery .
Transdermal and Topical CBD Delivery: Patches, Gels, and Colloidal Systems
Transdermal delivery systems, such as gels and dissolving microneedle patches, provide a noninvasive route for sustained CBD release and are particularly useful for chronic pain management. These systems can achieve steady-state plasma concentrations and, when combined with permeation enhancers, can significantly increase CBD absorption through the skin 37. Nanosuspension-loaded microneedle patches have demonstrated improved skin penetration, extended duration of action, and enhanced bioavailability, making them effective for localized conditions like knee synovitis . Topical colloidal formulations, including gels and aqueous colloidal solutions, have shown superior delivery of CBD to targeted skin layers compared to conventional products, which is beneficial for dermatological applications .
Intranasal and Transmucosal CBD Delivery: Rapid and Efficient Absorption
Intranasal (IN) delivery of CBD allows for rapid absorption into the bloodstream, achieving high bioavailability (34–46%) within minutes, making it suitable for acute or breakthrough pain 17. Transmucosal routes, such as buccal (cheek) administration using nanoemulsions, also provide fast onset and higher, more consistent plasma concentrations compared to oral administration. These nanoemulsions are easy to administer, offer better dose control, and overcome the variability seen with traditional oral formulations 18.
Advanced Drug Delivery Systems (ADDS) and Future Directions
Advanced drug delivery systems (ADDS), including nanoemulsions, microneedles, and colloidal carriers, are being actively developed to overcome CBD’s physicochemical limitations. These systems improve dissolution, protect CBD from degradation, and enable site-specific or controlled release, which can enhance therapeutic outcomes for various indications, especially neurological and dermatological disorders 16. While these novel delivery methods show promise in improving bioavailability and efficacy, more research is needed to determine if these pharmacokinetic improvements translate to better clinical outcomes for specific conditions .
Conclusion
CBD delivery methods have evolved significantly, with lipid-based oral formulations, nanoemulsions, transdermal patches, microneedles, and transmucosal systems all showing potential to improve bioavailability, absorption consistency, and therapeutic effectiveness. Each method offers unique advantages depending on the desired onset, duration, and site of action. Continued research and clinical studies will help clarify which delivery systems are best suited for specific therapeutic uses of CBD.
Sources and full results
Most relevant research papers on this topic
Strategies to Improve Cannabidiol Bioavailability and Drug Delivery
Novel oral CBD products and delivery strategies, such as lipid-based solutions and emulsions, improve bioavailability and drug delivery, but more research is needed to determine their therapeutic efficacy.
Harnessing therapeutic deep eutectic solvents in self-emulsifying systems to improve CBD delivery.
The CBD-based therapeutic deep eutectic solvent (THEDES) can be effectively incorporated into self-emulsifying drug delivery systems, offering an alternative method for therapeutic CBD delivery and protecting it from harsh gastric environments.
Current trends on cannabidiol delivery systems: where are we and where are we going?
Advanced CBD delivery systems (CBD-ADSs) can overcome physicochemical drawbacks and improve bioavailability, making CBD administration clinically effective for treating neurological disorders.
Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers
CBD can be successfully delivered through both intranasal and transdermal routes, with permeation enhancers potentially improving bioavailability for chronic pain treatment.
Enhancing transmucosal delivery of CBD through nanoemulsion: in vitro and in vivo studies
The CBD-NE nanoemulsion offers a promising alternative for buccal CBD administration, enhancing bioavailability, control of administered doses, and faster dissolution compared to conventional solutions.
A Novel Self-Emulsifying Drug Delivery System (SEDDS) Based on VESIsorb® Formulation Technology Improving the Oral Bioavailability of Cannabidiol in Healthy Subjects
SEDDS-CBD significantly improves oral bioavailability of cannabidiol in healthy subjects, with faster absorption and no safety concerns observed.
Pharmacokinetic Investigation of Synthetic Cannabidiol Oral Formulations in Healthy Volunteers.
Nano-emulsifying drug delivery system (SNEDDS) provides a reliable and predictable oral delivery of synthetic CBD, offering a standardized method for cannabinoid pharmacokinetics.
DOI